![](/images/graphics-bg.png)
A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention
المؤلفون المشاركون
Wu, Huan-Lin
Wang, Yun-Fei
Li, Jun-Zhe
Zhang, Min-Zhou
Sheng, Xiao-Gang
Wang, Xia
Li, Song
Chen, Qiu-Xiong
Li, Xiao-Qing
Ou, Ai-hua
Ruan, Xin-Min
المصدر
Evidence-Based Complementary and Alternative Medicine
العدد
المجلد 2014، العدد 2014 (31 ديسمبر/كانون الأول 2014)، ص ص. 1-7، 7ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2014-05-26
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الملخص EN
Percutaneous coronary intervention (PCI) is widely used in clinical treatment of coronary artery disease.
However, the effects of PCI on preventing restenosis after revascularization and improving the quality of life were not satisfying.
Huxin Formula is formulated by modifying an experienced Chinese medicine formula and has been widely used in clinical practice due to its marked effects on coronary heart disease.
A multicentre double-blind randomized controlled clinical trial was designed to evaluate the effects and safety of Huxin Formula in patients undergoing PCI.
Our results showed that there was no significant difference between the two groups in main outcomes.
For patients with ejection fraction (EF) > 50%, score of the quality of life scale was higher in treatment group compared with control group.
For patients with unstable angina, score of the quality of life scale in 360 days was significantly higher in treatment group compared with control group ( P < 0.05 ).
No obvious adverse reaction was found in the use of Huxin Formula.
In conclusion, Huxin Formula, believed to be a safe treatment for patients after PCI, has benefits in improving the quality of life in patients with unstable angina though it failed to show superiority in primary and secondary outcomes.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Wu, Huan-Lin& Wang, Yun-Fei& Li, Jun-Zhe& Zhang, Min-Zhou& Sheng, Xiao-Gang& Wang, Xia…[et al.]. 2014. A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention. Evidence-Based Complementary and Alternative Medicine،Vol. 2014, no. 2014, pp.1-7.
https://search.emarefa.net/detail/BIM-1018138
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Wu, Huan-Lin…[et al.]. A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention. Evidence-Based Complementary and Alternative Medicine No. 2014 (2014), pp.1-7.
https://search.emarefa.net/detail/BIM-1018138
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Wu, Huan-Lin& Wang, Yun-Fei& Li, Jun-Zhe& Zhang, Min-Zhou& Sheng, Xiao-Gang& Wang, Xia…[et al.]. A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention. Evidence-Based Complementary and Alternative Medicine. 2014. Vol. 2014, no. 2014, pp.1-7.
https://search.emarefa.net/detail/BIM-1018138
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1018138
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)